Please use this identifier to cite or link to this item:
Title: Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases.
Authors: Santucci, Matteo
Spyrakis, Francesca
Cross, Simon
Quotadamo, Antonio
Farina, Davide
Tondi, Donatella
De Luca, Filomena
Docquier, Jean-Denis
Prieto, Ana Isabel
Ibacache, Claudia
Blázquez, Jesús
Venturelli, Alberto
Cruciani, Gabriele
Costi, Maria Paola
metadata.dc.subject.mesh: Anti-Bacterial Agents
Bacterial Proteins
Boronic Acids
Computational Biology
Drug Resistance, Bacterial
Enterobacteriaceae Infections
Microbial Sensitivity Tests
beta-Lactamase Inhibitors
Issue Date: 18-Dec-2017
Abstract: β-Lactamases (BLs) able to hydrolyze β-lactam antibiotics and more importantly the last resort carbapenems, represent a major mechanism of resistance in Gram-negative bacteria showing multi-drug or extensively drug resistant phenotypes. The early detection of BLs responsible of resistant infections is challenging: approaches aiming at the identification of new BLs inhibitors (BLI) can thus serve as the basis for the development of highly needed diagnostic tools. Starting from benzo-[b]-thiophene-2-boronic acid (BZB), a nanomolar inhibitor of AmpC β-lactamase (K i  = 27 nM), we have identified and characterized a set of BZB analogues able to inhibit clinically-relevant β-lactamases, including AmpC, Extended-Spectrum BLs (ESBL), KPC- and OXA-type carbapenemases and metallo-β-lactamases (MBL). A multiligand set of boronic acid (BA) β-lactamase inhibitors was obtained using covalent molecular modeling, synthetic chemistry, enzyme kinetics and antibacterial susceptibility testing. Data confirmed the possibility to discriminate between clinically-relevant β-lactamases on the basis of their inhibition profile. Interestingly, this work also allowed the identification of potent KPC-2 and NDM-1 inhibitors able to potentiate the activity of cefotaxime (CTX) and ceftazidime (CAZ) against resistant clinical isolates (MIC reduction, 32-fold). Our results open the way to the potential use of our set of compounds as a diagnostic tool for the sensitive detection of clinically-relevant β-lactamases.
metadata.dc.identifier.doi: 10.1038/s41598-017-17399-7
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5735191.pdf3,09 MBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons